159 related articles for article (PubMed ID: 21390503)
1. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.
Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C
Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503
[TBL] [Abstract][Full Text] [Related]
2. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
3. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
Xu G; Zhang J
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
[TBL] [Abstract][Full Text] [Related]
4. Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.
Shu ST; Dirksen WP; Lanigan LG; Martin CK; Thudi NK; Werbeck JL; Fernandez SA; Hildreth BE; Rosol TJ
Leuk Lymphoma; 2012 Apr; 53(4):688-98. PubMed ID: 21942940
[TBL] [Abstract][Full Text] [Related]
5. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
6. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
7. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
8. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20.
Malewicz M; Zeller N; Yilmaz ZB; Weih F
J Biol Chem; 2003 Aug; 278(35):32825-33. PubMed ID: 12813034
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
[TBL] [Abstract][Full Text] [Related]
10. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM
Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795
[TBL] [Abstract][Full Text] [Related]
11. CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin.
Li Y; Shively JE
Exp Cell Res; 2013 May; 319(8):1061-72. PubMed ID: 23499736
[TBL] [Abstract][Full Text] [Related]
12. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
13. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing.
Takamizawa S; Okamoto S; Wen J; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2000 Feb; 35(2):375-9. PubMed ID: 10693700
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD).
Yamada N; Noguchi S; Kumazaki M; Shinohara H; Miki K; Naoe T; Akao Y
Biochim Biophys Acta; 2014 Mar; 1843(3):590-602. PubMed ID: 24316133
[TBL] [Abstract][Full Text] [Related]
16. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
[TBL] [Abstract][Full Text] [Related]
17. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice.
Deguchi Y; Kehrl JH
Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351
[TBL] [Abstract][Full Text] [Related]
18. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis.
Xerri L; Devilard E; Hassoun J; Haddad P; Birg F
Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420
[TBL] [Abstract][Full Text] [Related]
19. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.
Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB
Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071
[TBL] [Abstract][Full Text] [Related]
20. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
